We are live on
!
Find out more
MAA
Managed Account Advisors Portfolio holdings
AUM
$121B
1-Year Est. Return
7.32%
This Fund
S&P 500
This Quarter
Est. Return
+5.07%
1 Year Est. Return
+7.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101B
AUM Growth
+$11.3B
(+13%)
Cap. Flow
+$7.67B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
2,867
New
173
Increased
1,129
Reduced
1,339
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$467M |
| 2 |
Kinder Morgan
KMI
|
+$364M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$330M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$291M |
| 5 |
iShares MBS ETF
MBB
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$305M |
| 2 |
Gilead Sciences
GILD
|
+$142M |
| 3 |
Halliburton
HAL
|
+$107M |
| 4 |
GSK
GSK
|
+$81.3M |
| 5 |
Microsoft
MSFT
|
+$81.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.47% |
| 2 | Healthcare | 12.04% |
| 3 | Technology | 11.57% |
| 4 | Industrials | 9.75% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Lifecore Biomedical
LFCR
$165M
| $1.75M | ﹤0.01% |
126,590
-3,034
| -2% | -$39.2K |
|
1827
ANI Pharmaceuticals
ANIP
$1.84B
| $1.74M | ﹤0.01% |
+30,925
| New | +$1.36M |
|
|
CONE
1828
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.74M | ﹤0.01% |
63,150
-5,240
| -8% | -$138K |
|
|
NP
1829
DELISTED
Neenah, Inc. Common Stock
NP
| $1.74M | ﹤0.01% |
28,801
-2,624
| -8% | -$150K |
|
1830
Walker & Dunlop
WD
$1.75B
| $1.73M | ﹤0.01% |
98,852
+27,734
| +39% | +$441K |
|
1831
Plains GP Holdings
PAGP
$5.2B
| $1.73M | ﹤0.01% |
25,330
-110,401
| -81% | -$7.84M |
|
1832
Geospace Technologies
GEOS
$88.4M
| $1.73M | ﹤0.01% |
65,305
-21,736
| -25% | -$630K |
|
1833
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
| $1.73M | ﹤0.01% |
77,472
-31,031
| -29% | -$708K |
|
1834
ArcelorMittal
MT
$50.7B
| $1.73M | ﹤0.01% |
68,506
-4,240
| -6% | -$118K |
|
|
AVP
1835
DELISTED
Avon Products, Inc.
AVP
| $1.72M | ﹤0.01% |
183,422
-554,775
| -75% | -$5.74M |
|
1836
Flowers Foods
FLO
$1.6B
| $1.72M | ﹤0.01% |
89,472
-4,029
| -4% | -$76.1K |
|
1837
Westlake Corp
WLK
$9.25B
| $1.72M | ﹤0.01% |
28,074
+8,014
| +40% | +$546K |
|
|
USG
1838
DELISTED
Usg
USG
| $1.71M | ﹤0.01% |
61,227
+5,294
| +9% | +$145K |
|
1839
iShares Core Conservative Allocation ETF
AOK
$788M
| $1.71M | ﹤0.01% |
+52,329
| New | +$1.7M |
|
|
ELGX
1840
DELISTED
Endologix Inc
ELGX
| $1.7M | ﹤0.01% |
11,103
-8,485
| -43% | -$1.06M |
|
|
INWK
1841
DELISTED
InnerWorkings, Inc.
INWK
| $1.7M | ﹤0.01% |
217,783
-18,256
| -8% | -$145K |
|
1842
Vanguard Consumer Discretionary ETF
VCR
$6.01B
| $1.69M | ﹤0.01% |
14,442
+11,450
| +383% | +$1.28M |
|
|
RBS.PRH.CL
1843
DELISTED
Royal Bank Of Scotland Group
RBS.PRH.CL
| $1.68M | ﹤0.01% |
65,912
+529
| +0.8% | +$13.5K |
|
|
RRTS
1844
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $1.68M | ﹤0.01% |
2,875
-452
| -14% | -$250K |
|
1845
Option Care Health
OPCH
$3.53B
| $1.68M | ﹤0.01% |
59,975
+13,264
| +28% | +$329K |
|
1846
Motorcar Parts of America
MPAA
$267M
| $1.68M | ﹤0.01% |
53,879
-24,426
| -31% | -$736K |
|
1847
Vanguard FTSE Europe ETF
VGK
$30.2B
| $1.67M | ﹤0.01% |
31,900
+8,286
| +35% | +$444K |
|
|
PPO
1848
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $1.67M | ﹤0.01% |
35,408
-618
| -2% | -$28.1K |
|
1849
Center Bancorp
CNOB
$1.66B
| $1.66M | ﹤0.01% |
87,495
-10,028
| -10% | -$186K |
|
1850
National Bank Holdings
NBHC
$1.9B
| $1.66M | ﹤0.01% |
85,391
+4,299
| +5% | +$82.8K |
|
Similar funds
FSIM
HC
SCVF
CG
STI
HC
GMCM
RRC
Managed Account Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Managed Account Advisors held 2,867 positions worth $101B, up 13% from $89.7B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Managed Account Advisors deployed $7.67B of net new capital in Q4 2014, opening 173 new positions and adding to 1,129 existing holdings. Its largest new stake was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $142M trimmed.
- Managed Account Advisors's largest Q4 2014 buy was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.
- Managed Account Advisors added most to iShares Russell 1000 Growth ETF in Q4 2014, an estimated $467M increase.
- Managed Account Advisors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $142M.
- Managed Account Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $305M.
- Managed Account Advisors's ten largest holdings make up 9.1% of its $101B portfolio in Q4 2014.
- Managed Account Advisors opened 173 new positions and closed 119 in Q4 2014.
- Managed Account Advisors's portfolio value rose 13% quarter-over-quarter to $101B.
Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.